- Home
- JFBR vs SNPX Comparison
JFBR vs SNPX Comparison
Compare JFBR & SNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JFBR
- SNPX
- Stock Information
- Founded
- JFBR 2017
- SNPX 2012
- Country
- JFBR Israel
- SNPX United States
- Employees
- JFBR N/A
- SNPX N/A
- Industry
- JFBR Other Specialty Stores
- SNPX Medicinal Chemicals and Botanical Products
- Sector
- JFBR Consumer Discretionary
- SNPX Health Care
- Exchange
- JFBR Nasdaq
- SNPX Nasdaq
- Market Cap
- JFBR 3.6M
- SNPX 3.9M
- IPO Year
- JFBR 2022
- SNPX N/A
- Fundamental
- Price
- JFBR $1.73
- SNPX $2.87
- Analyst Decision
- JFBR
- SNPX Strong Buy
- Analyst Count
- JFBR 0
- SNPX 1
- Target Price
- JFBR N/A
- SNPX $14.00
- AVG Volume (30 Days)
- JFBR 298.8K
- SNPX 7.6K
- Earning Date
- JFBR 04-02-2025
- SNPX 03-31-2025
- Dividend Yield
- JFBR N/A
- SNPX N/A
- EPS Growth
- JFBR N/A
- SNPX N/A
- EPS
- JFBR N/A
- SNPX N/A
- Revenue
- JFBR $12,335,000.00
- SNPX N/A
- Revenue This Year
- JFBR N/A
- SNPX N/A
- Revenue Next Year
- JFBR N/A
- SNPX N/A
- P/E Ratio
- JFBR N/A
- SNPX N/A
- Revenue Growth
- JFBR 66.98
- SNPX N/A
- 52 Week Low
- JFBR $0.17
- SNPX $2.32
- 52 Week High
- JFBR $3.96
- SNPX $6.22
- Technical
- Relative Strength Index (RSI)
- JFBR 32.33
- SNPX 42.62
- Support Level
- JFBR $1.57
- SNPX $2.82
- Resistance Level
- JFBR $2.19
- SNPX $3.00
- Average True Range (ATR)
- JFBR 0.16
- SNPX 0.18
- MACD
- JFBR -0.05
- SNPX -0.03
- Stochastic Oscillator
- JFBR 20.78
- SNPX 8.22
About JFBR Jeffs' Brands Ltd
Jeffs Brands Ltd is an e-commerce CPG company, operating on Amazon. The company serves as the holding company of other e-commerce companies, Smart Repair Pro, Purex, and Top Rank, that operate online stores for the sale of various consumer products on Amazon online marketplace, utilizing the FBA model. The company has five wholly-owned subsidiaries: Smart Repair Pro, Purex, Top Rank , Fort and Jeffs' Brands Holdings. The company also utilizes internal methodologies to analyze sales data and patterns on Amazon in order to identify existing stores, niches and products that have the potential for development and growth, and for maximizing sales of existing proprietary products.
About SNPX Synaptogenix Inc.
Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.